Clinical Trial Update: Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating chemotherapy followed by donor white blood cells and interleukin-2 for acute myeloid leukemia and acute lymphoblastic leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Leukemia | Phase 1, Phase 2 | Status: COMPLETED